Regenerative Medicine Market
The Regenerative medicine market is expected to reach USD 38.70 Billion by 2021 from USD 13.41 Billion in 2016 at a CAGR of 23.6%.
The global market is broadly classified into types, therapy, application and regions. Based on types, the market is segmented into cell-based products and acellular products. The cell-based products is expected to dominate the global market in 2018.Based on therapy, the market is segmented into cell therapy, gene therapy, tissue engineering, and immunotherapy. Immunotherapy is the fastest growing segment in the global market, during the forecast period.
Related Conference of Regenerative Medicine Market
September 25-26, 2025
18th World Congress on Advances in Stem Cell Research and Regenerative Medicine
Montreal, Canada
October 27-28, 2025
20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Madrid, Spain
November 17-18, 2025
18th International Conference on Human Genomics and Genomic Medicine
Paris, France
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
Regenerative Medicine Market Conference Speakers
Recommended Sessions
- Anti-Aging, Regenerative and functional Medicine
- Applications of Tissue Engineering
- Artificial Organs
- Bio Banking
- Biomaterials and Bioengineering
- Biomedical Engineering Techniques
- Biotechnology and nanotechnology in stem cells
- Bone Tissue Engineering
- Cell and Organ Regeneration
- Cellular and gene Therapies
- Gene and Immunotherapy
- Oncology and study
- Regenerative Medicine Market
- Regenerative Rehabilitation
- Soft Tissue Replacement
- Stem Cell Bioprocessing
- Stem Cell Treatments
- Stem Cell Treatments
- Tissue Engineering
- Tissue Repair and Regeneration
- Tissue Repair and Regeneration
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2025 (Italy)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Cancer and stem cells - CRISPR 2025 (Italy)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- CRISPR technologies and society - CRISPR 2025 (Italy)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2025 (Italy)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome editing and gene regulation in human health - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2025 (Italy)
- Genome Editing Methods and Novel Tools - CRISPR 2025 (Italy)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Horizons of CRISPR biology - CRISPR 2025 (Italy)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Plant and Animal Biotechnology - CRISPR 2025 (Italy)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Structural Biology and Bioinformatics - CRISPR 2025 (Italy)
- Therapeutic Genome Editing - CRISPR 2025 (Italy)